Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intra‑arterial, intra‑articular, or intrathecal use. It enhances radiographic visualization of vascular, joint and cerebrospinal fluid spaces during diagnostic imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron, an iodinated contrast agent, is employed in imaging procedures that require enhanced radiodensity of vascular, joint, and cerebrospinal fluid spaces. - Angiography: provides clear visualization of blood vessels for diagnostic and interventional procedures. - Arthrography: improves contrast of joint spaces to assess cartilage, ligaments and intra‑articular pathology. - Myelography: delineates the spinal canal and cerebrospinal fluid for evaluation of spinal disorders. - Other diagnostic imaging procedures requiring intra‑arterial, intra‑articular, or intrathecal contrast: facilitates detailed imaging of targeted structures.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Nausea or mild vomiting. - Metallic taste in the mouth. - Headache. - Transient hypotension. - Mild injection‑site pain or bruising.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with respiratory distress. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Thyroid dysfunction due to iodine load. - Severe hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Neurological events such as seizures.

Prior to administration, clinicians should assess patient risk factors and follow appropriate safety measures. - Renal function assessment: evaluate baseline kidney function to identify patients at risk of contrast‑induced nephropathy. - Allergy history: screen for iodine or contrast media hypersensitivity and consider pre‑medication when appropriate. - Hydration: ensure adequate fluid intake before and after the procedure to reduce renal risk. - Thyroid status: assess thyroid function in patients with known disorders, as iodine load may affect hormone levels. - Pregnancy and lactation: use only when clearly necessary, weighing potential benefits against unknown fetal risk. - Store at below 25°C: keep in the original container, protect from moisture and light.

Iomeron can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Nephrotoxic drugs: concurrent use may increase risk of renal injury. - Metformin: consider temporary discontinuation in patients with impaired renal function. - Beta‑blockers: may mask contrast‑induced tachycardia, complicating monitoring. - Iodine‑containing medications: can increase total iodine load and risk of thyroid dysfunction. - High‑dose steroids: may potentiate adverse reactions.

Moderate Interactions (Monitor Closely): - Diuretics: monitor fluid balance and renal function closely. - ACE inhibitors/ARBs: watch for additive effects on blood pressure. - Antihistamines: may reduce mild allergic responses but do not replace emergency treatment. - Chemotherapeutic agents: assess cumulative nephrotoxicity risk. - Radiopharmaceuticals: consider total radiation exposure when used together.